DocGo Inc.
NASDAQ:DCGOMedical - Care Facilities
-$0.02 today
- Market cap
- $70.14M
- Beta
- 1.00
- P/E (TTM)
- -0.3
- EPS (TTM)
- -$1.90
Volume 1.64M
Average 0.87M
DCGO EBITDA Margin
EBITDA as a percentage of revenue.
DocGo Inc.NASDAQ: DCGO
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin narrows to -18.4%
EBITDA Margin was -18.4% in Q1 FY2026, down 7.4 pp from a year earlier. On a trailing-twelve-month basis it was -51.8%, down 54.6 pp year over year. Over 3 fiscal years it narrowed by 60.6 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 4 analysts of -4.8% for the fiscal year ending Dec 2026, up from -53.0% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -18.4%+125.3 pp QoQ
- Last fiscal yearDec 2025
- -53.0%-60.4 pp YoY
- LTMMar 2026
- -51.8%-54.6 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -7.4 pp | +12.0 pp | +19.4 pp |
| 1 year | -60.4 pp | +48.2 pp | +108.6 pp |
| 3 years | -60.6 pp | — | — |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -53.0%
- Year-over-year change
- -60.4pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -53.0% | -60.4pp |
| FY2024 | 2024-12-31 | 7.4% | +2.1pp |
| FY2023 | 2023-12-31 | 5.2% | -2.3pp |
| FY2022 | 2022-12-31 | 7.6% | -1.2pp |
| FY2021 | 2021-12-31 | 8.8% | — |
EBITDA Margin vs competitors
How DCGO compares with its peers on the latest reported figures
- DCGO's LTM Mar 2026 EBITDA Margin of -51.8% is the 2nd highest of the 7 companies compared; the peer median is -301.4%.
- Its year-over-year change of -54.6 pp is the lowest of 6, against a peer median of +218.0 pp.
- Over three fiscal years its change of -60.6 pp compares with a peer median of +32.0 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | -32.2% | -1.2 pp | +32.0 pp | |
| LTM Mar 2026 | -51.8% | -54.6 pp | -60.6 pp | |
| LTM Mar 2026 | -52.1% | +18.1 pp | +20.4 pp | |
| LTM Mar 2026 | -265.8% | +218.0 pp | — | |
| LTM Mar 2026 | -337.0% | +4411.9 pp | +3368.5 pp | |
| LTM Mar 2026 | -455.3% | +1345.3 pp | — | |
| LTM Mar 2026 | -13493.3% | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding DCGO) | -301.4% | +218.0 pp | +32.0 pp | |
Competitors are the stored peer set for DCGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 318.72M | 440.52M | 624.29M | 616.56M | 322.2M |
| Cost of Revenue | 208.97M | 285.79M | 428.91M | 402.98M | 223.44M |
| Gross Profit | 109.75M | 154.72M | 195.38M | 213.57M | 98.76M |
| Gross Margin | 34.4% | 35.1% | 31.3% | 34.6% | 30.7% |
| Research & Development | 3.32M | 5.38M | 10.86M | 11.59M | 13.56M |
| Selling, General & Admin | 83.56M | 116.94M | 153.04M | 157.41M | 158.69M |
| Operating Expenses | 94.39M | 132.89M | 180.33M | 184.89M | 187.91M |
| Depreciation & Amortization | 7.51M | 10.57M | 16.43M | 15.88M | 15.66M |
| EBITDA | 28.07M | 33.35M | 32.73M | 45.56M | (170.82M) |
| EBITDA Margin | 8.8% | 7.6% | 5.2% | 7.4% | -53.0% |
| Operating Income | 15.36M | 21.83M | 15.05M | 28.69M | (89.16M) |
| Operating Margin | 4.8% | 5.0% | 2.4% | 4.7% | -27.7% |
| Interest Income | 0 | 762.69K | 1.68M | 236.95K | 0 |
| Interest Expense | 763.03K | 0 | 0 | 2.17M | 1.01M |
| Other Income / Expenses | 4.44M | 950.26K | 1.24M | (939.72K) | (98.34M) |
| Income Before Tax | 19.8M | 22.78M | 16.29M | 27.75M | (187.5M) |
| Pre-Tax Margin | 6.2% | 5.2% | 2.6% | 4.5% | -58.2% |
| Income Tax Expense | 615.7K | (7.96M) | 6.24M | 14.39M | 8.87M |
| Net Income | 23.74M | 34.58M | 6.86M | 19.99M | (182.4M) |
| Net Margin | 7.4% | 7.9% | 1.1% | 3.2% | -56.6% |
| EPS (Basic) | 0.30 | 0.34 | 0.07 | 0.20 | (1.84) |
| EPS (Diluted) | 0.25 | 0.34 | 0.06 | 0.18 | (1.84) |
| Weighted Avg Shares | 80.29M | 101.23M | 103.51M | 102.4M | 99.07M |
| Weighted Avg Shares (Diluted) | 94.86M | 102.98M | 105.62M | 109.42M | 99.07M |
DocGo Inc.
NASDAQ:DCGO
Intrinsic Alpha fair value
Locked
Current Price
$0.71
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.